Myasthenia gravis represents chronic autoimmune disease that primarily targets the neuromuscular junction. This junction enables the conveyance of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system erroneously attacks these receptors, resulting weakness and fatigue in the muscles. The indications of m